Table of Contents Introduction What is the Mid-Sized Pharma Segment and What is its Role in the Industry? Why is Mid-size Pharma a Key Element of the Industry? Mid-size Pharma Players with Revenue Forecasts Comparative Analysis and Ranking - Based on Revenue R&D Expenditure Number of Pipeline Products Number of Marketed Products Number of Employees Location of Headquarter Year-on-Year Revenue Year-on-Year R&D Expenditure Key Points Mid-size Pharma Companies - Growth Strategies related to Deals and Collaborations Mergers and Acquisitions Licensing Agreements and Partnerships R&D Collaboration Geographical Expansion In-House Research and Development Shift towards High-Value Generics from Low-Value Generics Brand Building Specialized Therapy Areas and Rare Diseases Key Points Top Mid-size Pharma Companies Daiichi Sankyo Valeant Pharmaceuticals Eisai Regeneron Pharmaceuticals UCB Les Laboratories Servier Sun Pharmaceutical Endo International Mallinckrodt Kyowa Hakko Kirin Alexion Pharmaceuticals Taisho Pharmaceutical Overview Top Marketed Products Pipeline Overview Late stage Products with Sales Forecast Revenue Forecast Deals by Value and Volume Key Deals Top Small Pharma Companies Likely to Enter the Mid-size Segment Horizon Pharma Intas Pharmaceuticals Hypermarcas Challenges Faced by Mid-size Pharma Conclusion List of Mid-size Pharma Companies Bibliography Disclaimer